GE
Golden Eagle
Tesamorelin
103 tests · latest 17 Jun 2026
44%
NEA rating
#7 of 8 Tesamorelin vendors
17 of 31 classifiable tests passed
natural 93% · customers 3.9★ (15)
NEA analysis · Tesamorelin
Golden Eagle Tesamorelin has a notable caveat despite an acceptable purity signal at 95%: fill comes in light at 90.8% of label, a roughly 9% gap. Treat older lots with caution.
Balanced — purity 98%+, dose ±25%methodology
Peptides
5 rated · tap to focus| # | Peptide | Rating | N |
|---|---|---|---|
| 1 | Tesamorelinselected | 44% | 31 |
| 2 | GHRP 2 | 29% | 7 |
| 3 | Cagrilintide | 3% | 17 |
| 4 | Semaglutide | 0% | 22 |
| 5 | GHK Cu | 0% | 26 |
Rating trend
Tesamorelin rating from this vendor, after each test
Golden Eagle Tesamorelin test history
31 tests · 17 pass · 14 fail
| Date | Result | Purity | Dosage | Label |
|---|---|---|---|---|
| 17 Jun 2026 | Pass | 96.06%Identity Pass | -7.4%4.63 mg tested / 5 mg label | Batch TE202631sent by Public |
| 27 May 2026 | Fail | 96.84%Content Fail | -14.9%4.25 mg tested / 5 mg label | Batch TE202630sent by Public |
| 30 Apr 2026 | Pass | 95.4%Identity Pass | -4.3%4.79 mg tested / 5 mg label | Batch TE202629sent by Vendor |
| 7 Apr 2026 | Fail | 96.48%Content Fail | -15.8%4.21 mg tested / 5 mg label | Batch TE202628sent by Public |
| 13 Mar 2026 | Pass | 96.98%Identity Pass | -6.5%4.68 mg tested / 5 mg label | Batch TE202627sent by Vendor |
| 28 Feb 2026 | Pass | 96.73%Identity Pass | -6.2%4.69 mg tested / 5 mg label | Batch TE202626sent by Public |
| 16 Feb 2026 | Fail | 96.07%Content Fail | -14.8%4.26 mg tested / 5 mg label | Batch TE202625sent by Vendor |
| 2 Feb 2026 | Fail | 96.72%Content Fail | -20.2%3.99 mg tested / 5 mg label | Batch TE202624sent by Public |
| 9 Jan 2026 | Pass | 95.4%Identity Pass | -7.4%4.63 mg tested / 5 mg label | Batch TE202623sent by Vendor |
| 16 Dec 2025 | Pass | 96.69%Identity Pass | -4.8%4.76 mg tested / 5 mg label | Batch TE202622sent by Public |
1-10 of 31